OGEN

0.15708.72%
FW

Frederick W. Telling

Independent Director

Dr. Frederick W. Telling, also known as Fred, Ph.D., serves as Independent Director at Oragenics, Inc. since June 04, 2010. He had been an Executive Chairman at Oragenics, Inc. since May 2, 2021 until December 16, 2022. He was a Non-Executive Director of CTI BioPharma Corp., since December 2006. Dr. Telling served as a Vice President of Corporate Strategic planning and Policy for Pfizer Inc., from 1994 to 2007 and served as its Corporate Vice President. Dr. Telling was responsible for the management of Pfizer’s worldwide policy function and external representation of its interests to strengthen ability to anticipate and influence regulatory and competitive trends in the global marketplace. Dr. Telling was responsible for Pfizer’s policy development regarding the Prescription Drug User Fee Act’s original passage and all of its subsequent reauthorizations, health care reform, pricing and indigent access programs and other issues. He has invaluable experience. Since joining Pfizer in 1977, Dr. Telling served as an Associate Personnel Manager for Pharmaceuticals Division and progressed through a number of positions of increasing responsibility and also served as its Director of Planning for Pharmaceuticals Division since 1981. His responsibilities were expanded in 1987 and then served as Vice President of Planning for U.S. Pharmaceuticals at Pfizer. He was with Pfizer until June 2007 after several service and represented it in many industries related outside Boards. Dr. Telling had been an Independent Chairman of Oragenics Inc. since February 4, 2011 until May 2, 2021. He serves as a Director Emeritus of Orbis International, Inc. He has been Director of Oragenics Inc. since June 4, 2010. He serves as a Member of Board of Managers at Cytogel Pharma, LLC. He serves on the Board of Directors of Aequus Biopharma, Inc. Dr. Telling serves as a Director of Eisai N.A. Inc., and MEDEX Global Group. He serves as a Member of Healthcare & Life Sciences Advisory Council at IBM. He served as a Director of Biotechnology Innovation Organization for over few years. Dr. Telling serves as Vice Chairman for American Foundation for Pharmaceutical Education. He is a Member of the Board of California Health Care Institute and New England Healthcare Institute. Dr. Telling is actively involved in a number of charitable organizations, including the Boards of CED, National March of Dimes Foundation, United Hospital Fund, ORBIS, Smithsonian National Air and Space Museum and Experimental Aviation Association (EAA). He has extensive array of business and industry experience as well as experience as a Director of public companies. Dr. Telling retired from Pfizer Inc. in June 2007. At Pfizer Dr. Telling served as its Corporate Vice President and Vice President of Corporate Strategic Planning and Policy. He is a Member of the Metropolitan Club of Washington, DC. Dr. Telling is involved in the work of Council on Competitiveness, Business Roundtable, National Association of Manufacturers and Institute of Medicine. He is an invited Faculty Lecturer at Harvard University School of Public Health and Cornell University. He was a contributing author to the IOM’s series on Technology Innovation in Medicine at National Association of Manufacturers and Institute of Medicine. Dr. Telling holds a BA in History and Economics from Hamilton College and a MA degree in Industrial and Labor Relations and a PhD in Economics and Public Policy from Cornell University.

Positions